AAP
VERA icon

Arax Advisory Partners’s Vera Therapeutics VERA Stock Holding History

Arax Advisory Partners’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.88K Buy
67
+50
+294% +$1.86K ﹤0.01% 4727
2026
Q1 		$684 Buy
17
+8
+89% +$345 ﹤0.01% 3369
2025
Q4 		$456 Sell
9
-33
-79% -$1.17K ﹤0.01% 3625
2025
Q3 		$1.22K Buy
+42
New +$971 ﹤0.01% 3212
2024
Q4 		– Sell
-81
Closed -$3.58K – 2759
2024
Q3 		$3.58K Hold
81
– – ﹤0.01% 1851
2024
Q2 		$2.93K Buy
+81
New +$3.21K ﹤0.01% 1822

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Arax Advisory Partners's VERA Position: Q2 2026 in Review

Arax Advisory Partners increased its Vera Therapeutics (VERA) stake by 294% in Q2 2026, buying an estimated $1.86K and bringing the position to 67 shares worth $2.88K. The position accounts for ﹤0.01% of the portfolio, ranked #4727.

Arax Advisory Partners first reported a position in VERA in Q2 2024 and has held it in 6 quarters since. The position peaked at $3.58K in Q3 2024. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Arax Advisory Partners held 67 shares of Vera Therapeutics worth $2.88K as of Q2 2026.
  • Arax Advisory Partners bought 50 Vera Therapeutics shares in Q2 2026, an estimated $1.86K.
  • Vera Therapeutics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4727 holding.
  • Arax Advisory Partners first reported a position in Vera Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • Arax Advisory Partners's Vera Therapeutics position peaked at $3.58K in Q3 2024.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.